IVABRADINE-INDUCED TORSADES DE POINTES IN PATIENT WITH CONCURRENT USE OF HIGH DOSE METOPROLOL AND DIURETICS
2019
SHIFT trial showed reduced hospital admission rates and mortality with ivabradine, in patients with refractory sustained sinus tachycardia and heart failure with reduced ejection fraction (HFrEF). We present a case of a patient with normal QTc on maximum beta blocker therapy and aggressive diuretics
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI